Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities
Open Access
- 31 May 2020
- Vol. 12 (6), 1436
- https://doi.org/10.3390/cancers12061436
Abstract
Although improvement in early diagnosis and treatment ameliorated life expectancy of cancer patients, metastatic disease still lacks effective therapeutic approaches. Resistance to anticancer therapies stems from the refractoriness of a subpopulation of cancer cells—termed cancer stem cells (CSCs)—which is endowed with tumor initiation and metastasis formation potential. CSCs are heterogeneous and diverge by phenotypic, functional and metabolic perspectives. Intrinsic as well as extrinsic stimuli dictated by the tumor microenvironment (TME)have critical roles in determining cell metabolic reprogramming from glycolytic toward an oxidative phenotype and vice versa, allowing cancer cells to thrive in adverse milieus. Crosstalk between cancer cells and the surrounding microenvironment occurs through the interchange of metabolites, miRNAs and exosomes that drive cancer cells metabolic adaptation. Herein, we identify the metabolic nodes of CSCs and discuss the latest advances in targeting metabolic demands of both CSCs and stromal cells with the scope of improving current therapies and preventing cancer progression.Funding Information
- Associazione Italiana per la Ricerca sul Cancro (14415, 9979, 16746)
This publication has 207 references indexed in Scilit:
- ROS Production and NF-kappa B Activation Triggered by RAC1 Facilitate WNT-Driven Intestinal Stem Cell Proliferation and Colorectal Cancer InitiationCell Stem Cell, 2013
- A novel miR-155/miR-143 cascade controls glycolysis by regulatinghexokinase 2in breast cancer cellsThe EMBO Journal, 2012
- Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320Nature, 2011
- Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like propertiesBritish Journal of Cancer, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activityCell Death & Differentiation, 2010
- Cellular fatty acid uptake: a pathway under constructionTrends in Endocrinology & Metabolism, 2009
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolismNature, 2009
- SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell GrowthCell Metabolism, 2008
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003